Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Use of Visual Decision Aid for Shared Decision Making in Chest Pain

12 april 2022 bijgewerkt door: National University Hospital, Singapore

The Use of a Visual Decision Aid for Shared Decision Making Among Patients With Chest Pain

This study aims to evaluate the use of the chest pain choice (CPC) decision aid as a tool to facilitate discussion between the patient and his/her attending physician with regard to subsequent management plans. Patients aged 21 years and above with low-risk chest pain, as determined by the HEART score (HEART score 0-3), will be included. The investigator's hypothesis is that incorporating the Chest Pain Choice visual aid in shared decision making can help to reduce unnecessary admissions for low risk chest pain to the observation ward, as well as increase patient knowledge with regards to their own condition.

Studie Overzicht

Gedetailleerde beschrijving

Chest pain is a common presenting complaint in the Emergency Department (ED). Cardiac testing in low-risk patients poses unnecessary costs and resource utilisation, which may in part be due to clinicians adopting a very-low-risk threshold for discharge without testing.

The Chest Pain Choice (CPC) decision aid is a visual aid that was developed to facilitate shared decision-making between physicians and patients who present to the emergency department with chest pain, and has shown to be effective in increasing patient knowledge and decreasing the rate of admission to an observation unit for cardiac testing, among patients with chest pain who are at low risk for acute coronary syndromes. Shared decision making with the use of this visual aid has been shown in other centres to be associated with greater patient knowledge, greater patient involvement in decision making and less frequent admissions, with no increase in major adverse cardiac events (MACE) due to the intervention.

The visual aid includes a brief description of what tests have been done thus far to assess the patient's risk of MACE, a graphic representation of the risk as calculated based on the HEART score, as well as the evaluation options available. The visual aid has been modified from its original form for the local context in terms of viable options for further evaluation.

This study aims to assess if using a visual decision aid for shared decision making between physician and patient can safely help to decrease unnecessary admissions to the ED observation unit, as well as its impact on patient knowledge, satisfaction, as well as 30-day and 60-day Major Adverse Cardiac Events (MACE).

Studietype

Ingrijpend

Inschrijving (Werkelijk)

18

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • Central
      • Singapore, Central, Singapore, 119074
        • Mui Teng Chua

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

21 jaar tot 99 jaar (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Aged 21 years and above
  • Have low risk chest pain as defined by the HEART score (0-3 points)
  • Be English-literate
  • Have an initial serum troponin that is less than the 99th centile of the normal reference population
  • Have an initial electrocardiogram that is not suggestive of cardiac ischaemia

Exclusion Criteria:

  • Have a HEART score of 4 or more
  • Are not English-literate
  • Have an elevated initial serum troponin
  • Have an initial electrocardiogram that is suggestive of cardiac ischaemia (ST-segment depression or elevation, new onset left bundle brunch block, T-wave inversions, etc.)
  • Have known coronary artery disease
  • Have a prior plan for cardiac intervention or admission
  • Have barriers to outpatient follow-up
  • Are prisoners
  • Are pregnant
  • Are hearing or visually impaired, or are otherwise unable to use the clinical decision aid
  • Do not consent to participation in the study

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ander
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Intervention Arm
Patients in the intervention arm will receive the Chest Pain Choice visual aid prior to discussion with their primary physician regarding disposition.
The Chest Pain Choice (CPC) decision aid is a visual aid that was developed to facilitate shared decision-making between physicians and patients who present to the emergency department with chest pain. The visual aid includes a brief description of what tests have been done thus far to assess the patient's risk of MACE, a graphic representation of the risk as calculated based on the HEART score, as well as the evaluation options available. The visual aid has been modified from its original form for the local context in terms of viable options for further evaluation.
Geen tussenkomst: Control Arm
Patients in the control arm will not receive the Chest Pain Choice visual aid and will receive standard care.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Admission to the Emergency Department Observation Unit
Tijdsspanne: Index visit
Admission to the Emergency Department Observation Unit during index emergency department visit
Index visit

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Major Adverse Cardiac Events (MACE) at 30 days
Tijdsspanne: 30 days after index visit
MACE is defined as all-cause mortality, myocardial infarction or coronary revascularisation.
30 days after index visit
Major Adverse Cardiac Events at 60 days
Tijdsspanne: 60 days after index visit
MACE is defined as all-cause mortality, myocardial infarction or coronary revascularisation.
60 days after index visit
Emergency Department Attendance at 30 days
Tijdsspanne: 30 days after index visit
Repeat attendance to the emergency department
30 days after index visit
Emergency Department Attendance at 60 days
Tijdsspanne: 60 days after index visit
Repeat attendance to the emergency department
60 days after index visit
Stress treadmill electrogram at 30 days
Tijdsspanne: 30 days after index visit
The presence of stress treadmill electrocardiogram at 30 days post index visit
30 days after index visit
Stress treadmill electrogram at 60 days
Tijdsspanne: 60 days after index visit
The presence of stress treadmill electrocardiogram at 60 days post index visit
60 days after index visit
Stress myocardial perfusion imaging at 30 days
Tijdsspanne: 30 days after index visit
The presence of stress myocardial perfusion imaging at 30 days post index visit
30 days after index visit
Stress myocardial perfusion imaging at 60 days
Tijdsspanne: 60 days after index visit
The presence of stress myocardial perfusion imaging at 60 days post index visit
60 days after index visit
Stress echocardiogram at 30 days
Tijdsspanne: 30 days after index visit
The presence of stress echocardiogram at 30 days post index visit
30 days after index visit
Stress echocardiogram at 60 days
Tijdsspanne: 60 days after index visit
The presence of stress echocardiogram at 60 days post index visit
60 days after index visit
Computed tomography of the coronary arteries (CTCA) at 30 days
Tijdsspanne: 30 days after index visit
The presence of computed tomography of the coronary arteries (CTCA) at 30 days post index visit
30 days after index visit
Computed tomography of the coronary arteries (CTCA) at 60 days
Tijdsspanne: 60 days after index visit
The presence of computed tomography of the coronary arteries (CTCA) at 60 days post index visit
60 days after index visit

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

1 maart 2019

Primaire voltooiing (Werkelijk)

3 september 2021

Studie voltooiing (Werkelijk)

3 september 2021

Studieregistratiedata

Eerst ingediend

26 augustus 2018

Eerst ingediend dat voldeed aan de QC-criteria

14 september 2018

Eerst geplaatst (Werkelijk)

17 september 2018

Updates van studierecords

Laatste update geplaatst (Werkelijk)

20 april 2022

Laatste update ingediend die voldeed aan QC-criteria

12 april 2022

Laatst geverifieerd

1 augustus 2021

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

3
Abonneren